UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in INSM — INSMED Inc
CIK 861177
NEW YORK, NY
Position in INSM
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$198,680,883
+$34,507,912 QoQ
Shares Held
1,215,025
+28.8% QoQ
Ownership
0.561%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 50.81245241867451.ToString("F0")%
Shared 0.ToString("F0")%
None 49.18754758132549.ToString("F0")%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,605,812 across 211 Biotechnology names. INSM ranks #4 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
This page
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in INSM
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $198,680,883 | 1,215,025 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $164,172,971 | 943,306 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $73,840,978 | 512,749 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $70,041,508 | 695,961 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $41,157,230 | 539,484 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $33,611,910 | 486,847 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $30,874,328 | 422,936 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $29,296,085 | 437,255 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $11,042,584 | 407,025 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $12,630,592 | 407,570 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $9,181,654 | 363,630 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $7,443,190 | 352,758 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,014,520 | 352,758 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,100,349 | 355,373 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $7,078,688 | 328,630 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,902,927 | 451,467 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $10,785,441 | 458,955 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,510,960 | 128,890 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,178,113 | 115,400 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,500,577 | 123,000 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,964,718 | 116,404 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $3,791,828 | 113,903 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $3,330,859 | 103,636 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,913,757 | 105,801 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,605,531 | 100,158 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||